NCT06330779 Trauma-adapted Yoga in Child & Adolescent Psychiatry.
| NCT ID | NCT06330779 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University West, Sweden |
| Condition | ADHD |
| Study Type | INTERVENTIONAL |
| Enrollment | 180 participants |
| Start Date | 2025-02-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 180 participants in total. It began in 2025-02-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this randomized clinical trial is to evaluate the efficacy of trauma-adapted yoga as a complementary intervention to care as usual in child and adolescents psychiatry clinics, in the population of adolescents with the diagnosis of ADHD and/or PTSD. We hypothesize that trauma-adapted yoga (TAY) is an effective non-pharmacological intervention for adolescent with ADHD and/or PTSD. Aims: (1) Validate the impact of TAY on the mental health \& quality of life of adolescents with ADHD and/or PTSD. (2) Investigate the feasibility of online TAY for continued self-care. (3) Explore adolescents' experiences \& parental perspectives on TAY in their treatment. (4) Explore healthcare professionals' experience on the integration of TAY into clinical practice. Within and between group (yoga group vs waiting list) analyses will be performed.
Eligibility Criteria
Inclusion Criteria: * Adolescents who have received a diagnosis (not under evaluation) of PTSD and/or ADHD * Understanding English or Swedish languages. Exclusion Criteria: * Ongoing substance use, * active manic periods, * psychotic disorders, * suicidality, * cognitive impairment. * serious physical illness prohibiting participation in physical activities.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06330779 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 18 Years, studying ADHD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06330779 currently recruiting?
Yes, NCT06330779 is actively recruiting participants. Contact the research team at nora.kerekes@hv.se for enrollment information.
Where is the NCT06330779 trial being conducted?
This trial is being conducted at Gothenburg, Sweden.
Who is sponsoring the NCT06330779 clinical trial?
NCT06330779 is sponsored by University West, Sweden. The trial plans to enroll 180 participants.